Questions a plan sponsor actually asks.
What is Everolimus Tablets used for?
Everolimus Tablets targets specific kinase enzymes involved in cancer cell growth and proliferation.
Is there a generic for Everolimus Tablets?
No. Everolimus Tablets is brand-only with no generic equivalents currently in market.
How much does my plan pay for Everolimus Tablets?
Across 329 Part D plans, Everolimus Tablets averages $5.16/unit (NADAC). Lowest available: $2.29/unit. Highest in distribution: $9.07/unit.
Is Everolimus Tablets on the FDA shortage list?
No. Everolimus Tablets is not currently on the FDA Drug Shortage Database.
6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (7 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.